Medicare obesity drug coverage expansion faces awareness gap among U.S. seniors

Traders Union
All News
Financial News
Medicare obesity drug coverage gap

Highlights

Medicare's new Bridge program allows eligible beneficiaries to access obesity drugs starting Wednesday, requiring a prescription, prior authorization, and Part D enrollment.
A June survey by the Obesity Care Advocacy Network found 82% of older Americans are unaware Medicare will now cover obesity drugs, indicating a significant awareness gap.
CMS is prioritizing provider and pharmacist outreach at launch, planning broader beneficiary promotion later to ensure healthcare systems can manage potential surges in demand.

Bridge program launch and enrollment steps

As reported by CNBC, eligible Medicare beneficiaries can begin receiving obesity drugs through Medicare’s new Bridge demonstration program starting Wednesday, but enrollment is not automatic. Patients must meet eligibility requirements, obtain a prescription and secure prior authorization from the Centers for Medicare & Medicaid Services before coverage starts.

The new benefit is seen as a significant shift for patients, physicians and obesity advocates who have pushed for wider access to these high-profile medicines. Beneficiaries also must be enrolled in Part D, Medicare’s prescription drug plan, to qualify, even though the Bridge program itself is administered directly by CMS rather than through private Part D plans.

The quieter rollout differs from the broad consumer marketing campaigns that Novo Nordisk and Eli Lilly have used for obesity and diabetes medicines in the past. Because private insurers do not administer this benefit, they also do not have a central role in informing beneficiaries about the new coverage.

Low public awareness may slow early uptake

A survey released in early June by the Obesity Care Advocacy Network found that 82% of older Americans say they are unaware Medicare is about to cover obesity drugs. The poll, conducted in late March among more than 2,100 adults aged 65 and older, showed low awareness across party lines, including 79% of Republicans and 84% of Democrats.

CMS says it is focusing initial outreach on healthcare providers and pharmacists, with broader promotion planned after launch. An agency official told reporters on Thursday that beneficiaries are most likely to act when a benefit is actually available, adding that a later outreach push would also support careful use of taxpayer dollars.

Some physicians and other experts say the limited public messaging may reflect an effort to ensure providers, pharmacies and support systems are ready before demand rises sharply. They warn that the lack of awareness could delay treatment for some eligible seniors, even as access to the drugs becomes available.

In our earlier article on UnitedHealth Group (UNH), we noted that investor demand was supported by stabilizing medical cost trends and improving Medicare Advantage margins. The piece highlighted strong technical momentum alongside warnings that the stock was nearing overbought territory, making key resistance and support levels important for traders watching for a breakout or pullback.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.